SRx Health Solutions Inc. (SRXH)

SRx Health Solutions Income Statement

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022
Revenue	6.53	-	119.42	93.18
Revenue Growth (YoY)	-	-	28.16%	-
Cost of Revenue	5.01	-	95.72	79.8
Gross Profit	1.53	-	23.71	13.39
Selling, General & Admin	9.63	-	30.81	13.22
Operating Expenses	9.63	-	32.55	14.56
Operating Income	-8.11	-	-8.85	-1.17
Interest Expense	-0.63	-	-1.83	-0.76
Earnings From Equity Investments	-	-	-	-0.18
Other Non Operating Income (Expenses)	-	-	-0.13	0.09
EBT Excluding Unusual Items	-8.73	-	-10.81	-2.02
Merger & Restructuring Charges	-3.3	-	-0.18	-
Other Unusual Items	3.4	-	-	-
Pretax Income	-8.64	-	-10.99	-2.02
Income Tax Expense	-	-	0.2	0.44
Earnings From Continuing Operations	-8.64	-	-11.18	-2.46
Earnings From Discontinued Operations	-36.37	-43.05	-	-
Net Income	-45.01	-43.05	-11.18	-2.46
Net Income to Common	-45.01	-43.05	-11.18	-2.46
Shares Outstanding (Basic)	21	22	12	1
Shares Outstanding (Diluted)	21	22	12	1
Shares Change (YoY)	-4.40%	78.22%	1659.27%	-
EPS (Basic)	-2.13	-1.95	-0.90	-3.50
EPS (Diluted)	-2.13	-1.95	-0.90	-3.50
Free Cash Flow	-16.67	-1.48	1.58	3.15
Free Cash Flow Per Share	-0.79	-0.07	0.13	4.48
Gross Margin	23.36%	-	19.85%	14.36%
Operating Margin	-124.06%	-	-7.41%	-1.26%
Profit Margin	-688.80%	-	-9.36%	-2.64%
Free Cash Flow Margin	-255.07%	-	1.32%	3.38%
EBITDA	-8.08	-	-7.07	-0.54
EBITDA Margin	-123.58%	-	-5.92%	-0.58%
D&A For EBITDA	0.03	4.39	1.77	0.63
EBIT	-8.11	-	-8.85	-1.17
EBIT Margin	-124.06%	-	-7.41%	-1.26%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q